API
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 5 sources · 11 days · First seen · Last updated

Cancer treatment research and clinical updates

Overview

Recent medical developments have introduced new standards and indicators for cancer treatment. Updated S3 guidelines for cervical carcinoma now recommend platinum and taxane-based chemotherapy combined with Pembrolizumab for recurrences and metastases, while suggesting more conservative surgical options. In prostate cancer research, the PEACE-1 study demonstrated that adding Abiraterone to standard hormone therapy and chemotherapy significantly improves survival rates for men with metastatic hormone-sensitive prostate cancer.

Further research has identified potential indicators for predicting immunotherapy effectiveness in stage II to III non-small cell lung cancer. By analyzing PET/CT scans, researchers found that a reduction in the tumor-to-liver uptake ratio could help determine the likelihood of complete remission.

Regarding prostate cancer, a study involving over 3,000 patients indicated that long-term use of the bone protection drug denosumab for more than 13 months significantly increases the risk of osteonecrosis of the jaw, with a cumulative incidence of 12.2 percent.

Entities

ESMO · Matthias Beckmann · Korea University Guro Hospital · University Hospital Erlangen · Catholic University of Korea

Timeline

  1. [HEALTH] 5 sources
    Medical researchers identify new indicators for cancer treatment efficacy

    New medical studies reveal ways to predict lung cancer immunotherapy success via PET/CT scans and identify increased jaw necrosis risks for prostate cancer patients using denosumab for over 13 months.

  2. [HEALTH] 2 sources
    Medical guidelines and studies update cancer treatment standards

    Updated medical guidelines for cervical cancer and new long-term study data for prostate cancer indicate significant improvements in survival rates and more targeted treatment standards.

Sources

biz.heraldcorp.com · bosa.co.kr · healthmedia.co.kr · namdonews.com · sportschosun.com